What it does
D'OXYVA® (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, transdermal (over the skin) microcirculatory solution with industry-leading clinical research results that does not break the skin's barrier.
In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D'OXYVA is leading the field by quickly targeting to:
Significantly lower the risk of diabetes and cardiovascular complications
Provide complete healing of difficult wounds together with major pain relief and improved quality of life:
- Detoxify the skin and body
- Improve sleep
- Stamina and skin health
- Reduce inflammation
- And much more for all kinds of people
How it works
D'OXYVA's soft water and FDA-cleared medical CO2 vapor mixture readily dissolves in a molecular form in the skin to increase skin perfusion pressure, microcirculation.
It is non-electrical, handheld, painless, fast, and easy to use with no adverse side effects, according to years of user feedback and the results of past clinical trials with D'OXYVA.
It is an affordable, stand alone and adjunct application locally and all over the body. Taking D'OXYVA is easy; hold it against your skin surface for 5 minutes total, like comfortably inserting your thumb or anywhere you are hurt.
Increased oxygen-rich microcirculatory tissue perfusion is widely reported in published clinical research to improve physiological processes including but not limited to wound, tissue healing and repair, athletic performance, stamina, sleep quality, skin health, and much more.
D'OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain leading to major tissue perfusion, blood circulation in macro-, and microcirculation enhancement in controlled human clinical trials (Phase I to III). These benefits result in significant improvements of essential physiological processes and clinical outcomes.
Medical CO2 gas is a widely accepted so-called gasotransmitter acting as a natural vasodilator amongst other beneficial critical signaling funtions when delivered by D'OXYVA's patented and patent-pending process.
D'OXYVA delivers the highest possible concentration of CO2 and has been clinically studied to significantly increase lasting blood flow volume in the microcirculatory system.
In addition, increased microcirculation with CO2 is widely known to increase the perfusion of oxygen.
Shop All Products >